FLT3 and acute myeloid leukemia: Gain-of-function mutations and overexpression of kinases including FLT3-ITD, KRASG12D, KITN822K, and BTK, provide proliferative signals to AML (Fig. 6) by promoting cell cycle and inhibiting autophagy transcriptionally and post-translationally [39–43].